Tateo, Valentina; Ricci, Costantino; Melotti, Sofia; Tassinari, Elisa; Rosellini, Matteo; Marchetti, Andrea; Danielli, Linda; Maestri, Antonio; Necchi, Andrea; Mollica, Veronica; Fiorentino, Michelangelo; Massari, Francesco, Pathological and Clinical Implications of Tumor Microenvironment Evaluated With Multiplex Immunohistochemistry in Testicular Embryonal Carcinoma, «CLINICAL GENITOURINARY CANCER», 2025, 23, Article number: 102444, pp. 1 - 13 [articolo]
Porta, Camillo; Massari, Francesco; Taha, Tarek; Grande, Enrique; Bourlon, Maria T; Kanesvaran, Ravindran; Basso, Umberto; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Myint, Zin W; Fornarini, Giuseppe; Buttner, Thomas; Park, Se Hoon; Ürün, Yüksel; De Giorgi, Ugo; Pichler, Renate; Rescigno, Pasquale; Buchler, Tomas; Studentova, Hana; Melichar, Bohuslav; Ansari, Jawaher; Mollica, Veronica; Kucharz, Jakub; Rizzo, Mimma; Rizzo, Alessandro; Kopp, Ray Manneh; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Bamias, Aristotelis; Santoni, Matteo, Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON-1 study, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2025, 74, Article number: 196, pp. 1 - 11 [articolo]Open Access
Santoni, Matteo; Roviello, Giandomenico; Grande, Enrique; De Giorgi, Ugo; Fiala, Ondrej; Seront, Emmanuel; Molina-Cerrillo, Javier; Pichler, Renate; Myint, Zin W; Kucharz, Jakub; Kanesvaran, Ravindran; Büttner, Thomas; Pichler, Martin; Basso, Umberto; Kopecky, Jindrich; Bourlon, Maria T; Cerbone, Linda; Buchler, Tomas; Pinto, Alvaro; De Liaño, Alfonso Gómez; Gianni, Caterina; Zgura, Anca; Rescigno, Pasquale; Ansari, Jawaher; Caffo, Orazio; Küronya, Zsófia; Vitale, Maria Giuseppa; Bhuva, Dipen; Catalano, Martina; Vau, Nuno; Kopp, Ray Manneh; Buti, Sebastiano; Bamias, Aristotelis; Porta, Camillo; Sunela, Kaisa; Massari, Francesco, Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1), «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2025, 74, Article number: 225, pp. 1 - 12 [articolo]Open Access
Rizzo, Alessandro; Zayed, Anas; Vitale, Elsa; Buti, Sebastiano; Takeshita, Hideki; Crabb, Simon; Roviello, Giandomenico; Seront, Emmanuel; Tapia, Jose Carlos; Scagliarini, Sarah; Popovic, Lazar; Kopp, Ray Manneh; Abahssain, Halima; Rizzo, Mimma; Monteiro, Fernando Sabino Marques; Massafra, Raffaella; Brunetti, Oronzo; Santini, Daniele; Ürün, Yüksel; Montironi, Rodolfo; Mollica, Veronica; Massari, Francesco; Soares, Andrey; Santoni, Matteo, Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset, «CLINICAL & EXPERIMENTAL METASTASIS», 2025, 42, pp. 1 - 10 [articolo]
Massari, Francesco; Rosellini, Matteo; Marchetti, Andrea; Santoni, Matteo; Mollica, Veronica, Re: First-line Therapy for Advanced Non-Clear Cell Renal Cell Carcinoma. A Systematic Review and Meta-analysis, «EUROPEAN UROLOGY», 2025, 1, pp. 1 - 2 [articolo]
Santoni, Matteo; Massari, Francesco, Re: Using Deep Learning To Differentiate Among Histology Renal Tumor Types in Computed Tomography Scans, «EUROPEAN UROLOGY», 2025, 1, pp. 1 - 2 [articolo]
Rizzo, Mimma; Morelli, Franco; Ürün, Yüksel; Buti, Sebastiano; Park, Se Hoon; Bourlon, Maria T; Grande, Enrique; Massari, Francesco; Landmesser, Johannes; Poprach, Alexandr; Takeshita, Hideki; Roviello, Giandomenico; Myint, Zin W; Popovic, Lazar; Soares, Andrey; Abahssain, Halima; Giannatempo, Patrizia; Molina-Cerrillo, Javier; Incorvaia, Lorena; Salah, Samer; Zeppellini, Annalisa; Monteiro, Fernando Sabino Marques; Porta, Camillo; Gupta, Shilpa; Santoni, Matteo, Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience, «CANCER MEDICINE», 2025, 14, pp. 1 - 12 [articolo]Open Access
Kopp, Ray Manneh; Massari, Francesco; Grande, Enrique; Schieber, Timothy J; Ürün, Yüksel; Kopecký, Jindřich; Molina-Cerrillo, Javier; Basso, Umberto; Kucharz, Jakub; Büttner, Thomas; Pichler, Renate; Fiala, Ondrej; Myint, Zin W; Galli, Luca; Buchler, Tomas; Rizzo, Mimma; Bolek, Hatice; Bourlon, Maria T; Conteduca, Vincenza; Pinto, Alvaro; Rizzo, Alessandro; Rosellini, Matteo; Roviello, Giandomenico; Zgura, Anca; Mollica, Veronica; Partl, Antonia; Yildirim, Ahmet; Akova, Umut; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Porta, Camillo; Bilen, Mehmet Asim; Li, Haoran; Santoni, Matteo, Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2025, 74, Article number: 374, pp. 1 - 10 [articolo]Open Access
Bruno, Giuseppina; Natalicchio, Maria Iole; Garofoli, Marianna; Lolli, Cristian; Rosano, Aldo; Tullio, Piergiorgio Di; Giordano, Guido; Mancino, Alice; Masucci, Mariachiara; Chiuri, Vincenzo Emanuele; Fratino, Lucia; Zanardi, Elisa; Schepisi, Giuseppe; Galli, Luca; Massari, Francesco; Santoni, Matteo; Brighi, Nicole; Cornacchia, Elisabetta; Rescigno, Pasquale; Fornarini, Giuseppe; Sanguedolce, Francesca; Santini, Daniele; Procopio, Giuseppe; Caffo, Orazio; Giorgi, Ugo De; Landriscina, Matteo; Conteduca, Vincenza, Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience, «EUROPEAN UROLOGY ONCOLOGY», 2025, Article In Press, pp. 1 - 11 [articolo]Open Access
Molina-Cerrillo, Javier; Roviello, Giandomenico; Fiala, Ondrej; Taha, Tarek; Buti, Sebastiano; Rizzo, Mimma; Massari, Francesco; Monteiro, Fernando Sabino Marques; Santoni, Matteo, Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)", «INTERNATIONAL JOURNAL OF CANCER», 2025, 1, pp. 1 - 3 [articolo]
Corianò, Matilde; Lazzarin, Alessandro; Maffezzoli, Michele; Santoni, Matteo; Mazzaschi, Giulia; Rodella, Sara; Simoni, Nicola; Lai, Eleonora; Maruzzo, Marco; Basso, Umberto; Bimbatti, Davide; Iacovelli, Roberto; Anghelone, Annunziato; Fiala, Ondřej; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Lolli, Cristian; Massari, Francesco; Rosellini, Matteo; Mollica, Veronica; Nasso, Cecilia; Acunzo, Alessandro; Silini, Enrico Maria; Quaini, Federico; De Filippo, Massimo; Brunelli, Matteo; Banna, Giuseppe L; Rescigno, Pasquale; Signori, Alessio; Buti, Sebastiano, Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations, «IMMUNOTHERAPY», 2025, 17, pp. 25 - 35 [articolo]
Massari, Francesco; Rosellini, Matteo; Melichar, Bohuslav; Grande, Enrique; Bourlon, Maria T; Li, Haoran; Fiala, Ondřej; Park, Se Hoon; Fita, Maria José Juan; Taha, Tarek; Molina-Cerrillo, Javier; Santini, Daniele; De Liañ, Alfonso Gómez; Büttner, Thomas; Scagliarini, Sarah; Manneh Kopp, Ray; Zeppellini, Annalisa; Ghosn, Marwan; Conteduca, Vincenza; Bölek, Hatice; Rizzo, Alessandro; Ansari, Jawaher; Mollica, Veronica; Zgura, Anca; Filosa, Alessandra; Yildirim, Ahmet; Akova, Umut; Monteiro, Fernando Sabino Marques; Buti, Sebastiano; Soares, Andrey; Bilen, Mehmet Asim; Ürün, Yüksel; Santoni, Matteo, Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study, «JCO GLOBAL ONCOLOGY», 2025, 11, Article number: e2500376, pp. 1 - 12 [articolo]Open Access
Incorvaia, Lorena; Scagliarini, Sarah; Marques Monteiro, Fernando Sabino; Takeshita, Hideki; Tapia, Jose Carlos; Gandur Quiroga, María Natalia; Lam, Elaine; Tural, Deniz; Popovic, Lazar; Campos-Gomez, Saul; Zucali, Paolo Andrea; Mota, Augusto; Ortega, Cinzia; Sade, Juan Pablo; Rizzo, Mimma; Fiala, Ondřej; Vau, Nuno; Giannatempo, Patrizia; Abahssain, Halima; Galosi, Andrea Benedetto; Badalamenti, Giuseppe; Kopecky, Jindrich; Bamias, Aristotelis; Landmesser, Johannes; Ansari, Jawaher; Calabrò, Fabio; Massari, Francesco; Buti, Sebastiano; Bellmunt, Joaquim; Santoni, Matteo, Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab, «SCIENTIFIC REPORTS», 2025, 15, Article number: 8815, pp. 1 - 9 [articolo]Open Access
Tassinari, Elisa; Danielli, Linda; Marchetti, Andrea; Rosellini, Matteo; Ricci, Costantino; Piazza, Pietro; Mottaran, Angelo; Schiavina, Riccardo; Santoni, Matteo; Mollica, Veronica; Massari, Francesco, State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes, «HUMAN VACCINES & IMMUNOTHERAPEUTICS», 2025, 21, Article number: 2440165, pp. 1 - 16 [articolo]Open Access
Vescovo, Mariavittoria; Raspollini, Maria Rosaria; Nibid, Lorenzo; Castiglione, Francesca; Nardi, Eleonora; de Biase, Dario; Massari, Francesco; Giunchi, Francesca; Pepe, Francesco; Troncone, Giancarlo; Malapelle, Umberto; Carosi, Mariantonia; Casini, Beatrice; Melucci, Elisa; Fassan, Matteo; Toffolatti, Luisa; Guerini-Rocco, Elena; Conversano, Federica; Rappa, Alessandra; Tommasi, Stefania; Coppola, Claudio Antonio; Zeppa, Pio; Caputo, Alessandro; Gaeta, Sara; Pagni, Fabio; Seminati, Davide; Vecchione, Andrea; Scarpino, Stefania; Righi, Daniela; Taffon, Chiara; Prata, Francesco; Perrone, Giuseppe, Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications, «CANCERS», 2025, 17, Article number: 1705, pp. 1 - 12 [articolo]Open Access
